MetaADEDB 2.0 @ LMMD
Buspirone
(RICLFGYGYQXUFH-UHFFFAOYSA-N)
Structure
SMILES
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1.Cl
Molecular Formula:
C21H32ClN5O2
Molecular Weight:
421.964
Log P:
2.8310
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
69.64
CAS Number(s):
33386-08-2
Synonym(s)
1.
Buspirone
2.
Anxut
3.
Apo-Buspirone
4.
Bespar
5.
Busp
6.
Buspar
7.
Buspirone Hydrochloride
8.
Gen-Buspirone
9.
Lin-Buspirone
10.
MJ-9022-1
11.
N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide
12.
Neurosine
13.
Novo-Buspirone
14.
Nu-Buspirone
15.
PMS-Buspirone
16.
Ratio-Buspirone
17.
Apo Buspirone
18.
Gen Buspirone
19.
Hydrochloride, Buspirone
20.
Lin Buspirone
21.
MJ 9022 1
22.
MJ90221
23.
Novo Buspirone
24.
Nu Buspirone
25.
PMS Buspirone
26.
Ratio Buspirone
External Link(s)
MeSHD002065
PubChem Compound25137845
44658940
36431
BindingDB50367352
ChEBI3224
CHEMBLCHEMBL1200399
KEGGdr:D00702
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 53US FAERS
2DizzinessFAERS: 33US FAERS
3NauseaFAERS: 28US FAERS
4AnxietyFAERS: 24US FAERS
5Feeling abnormalFAERS: 15US FAERS
6HeadacheFAERS: 14US FAERS
7Pharmaceutical product complaintFAERS: 14US FAERS
8PregnancyFAERS: 11US FAERS
9SomnolenceFAERS: 11US FAERS
10Chest PainFAERS: 9US FAERS
11PalpitationsFAERS: 9US FAERS
12TremorFAERS: 9US FAERS
13AgitationFAERS: 8US FAERS
14Drug screen positiveFAERS: 8US FAERS
15VomitingFAERS: 8US FAERS
16FatigueFAERS: 7US FAERS
17SyncopeFAERS: 7US FAERS
18UrticariaFAERS: 7US FAERS
19OverdoseFAERS: 6US FAERS
20TinnitusFAERS: 6US FAERS
21CryingFAERS: 5US FAERS
22Drug screen false positiveFAERS: 5US FAERS
23Drug withdrawal syndromeFAERS: 5US FAERS
24Medication ErrorFAERS: 5US FAERS
25NervousnessFAERS: 5US FAERS
26PruritusFAERS: 5US FAERS
27AlopeciaFAERS: 4US FAERS
28AmnesiaFAERS: 4US FAERS
29AngerFAERS: 4US FAERS
30ArthralgiaFAERS: 4US FAERS
31AstheniaFAERS: 4US FAERS
32Chest discomfortFAERS: 4US FAERS
33DysgeusiaFAERS: 4US FAERS
34HypersensitivityFAERS: 4US FAERS
35MalaiseFAERS: 4US FAERS
36Product quality issueFAERS: 4US FAERS
37Product substitution issueFAERS: 4US FAERS
38Abdominal PainFAERS: 3US FAERS
39Adverse eventFAERS: 3US FAERS
40Completed SuicideFAERS: 3US FAERS
41EpistaxisFAERS: 3US FAERS
42HypersomniaFAERS: 3US FAERS
43Incorrect dose administeredFAERS: 3US FAERS
44Maternal exposure during pregnancyFAERS: 3US FAERS
45MyalgiaFAERS: 3US FAERS
46Pre-EclampsiaFAERS: 3US FAERS
47Reaction to drug excipientsFAERS: 3US FAERS
48RestlessnessFAERS: 3US FAERS
49Suicide attemptFAERS: 3US FAERS
50TachycardiaFAERS: 3US FAERS
51Tardive DyskinesiaFAERS: 3US FAERS
52Therapeutic response unexpected with drug substitutionFAERS: 3US FAERS
53Weight decreasedFAERS: 3US FAERS
54AbasiaFAERS: 2US FAERS
55Abdominal discomfortFAERS: 2US FAERS
56Back PainFAERS: 2US FAERS
57Blood glucose increasedFAERS: 2US FAERS
58Depressed moodFAERS: 2US FAERS
59DisorientationFAERS: 2US FAERS
60Drug dispensed to wrong patientFAERS: 2US FAERS
61Drug exposure during pregnancyFAERS: 2US FAERS
62DystoniaFAERS: 2US FAERS
63DysuriaFAERS: 2US FAERS
64EructationFAERS: 2US FAERS
65Erythema MultiformeFAERS: 2US FAERS
66ErythemaFAERS: 2US FAERS
67Feeling jitteryFAERS: 2US FAERS
68Flat affectFAERS: 2US FAERS
69Impaired driving abilityFAERS: 2US FAERS
70Incorrect route of drug administrationFAERS: 2US FAERS
71Mental status changesFAERS: 2US FAERS
72Musculoskeletal stiffnessFAERS: 2US FAERS
73Myocardial InfarctionFAERS: 2US FAERS
74No adverse eventFAERS: 2US FAERS
75Oropharyngeal painFAERS: 2US FAERS
76PainFAERS: 2US FAERS
77PhotophobiaFAERS: 2US FAERS
78Product dispensing errorFAERS: 2US FAERS
79Product physical issueFAERS: 2US FAERS
80Rash erythematousFAERS: 2US FAERS
81ShockFAERS: 2US FAERS
82ThirstFAERS: 2US FAERS
83Throat irritationFAERS: 2US FAERS
84Urinary RetentionFAERS: 2US FAERS
85Wrong patient received productFAERS: 2US FAERS
86Wrong technique in product usage processFAERS: 2US FAERS
87Accidental overdoseFAERS: 1US FAERS
88Acute respiratory failureFAERS: 1US FAERS
89AgeusiaFAERS: 1US FAERS
90Anal FissureFAERS: 1US FAERS
91Angle Closure GlaucomaFAERS: 1US FAERS
92AnorexiaFAERS: 1US FAERS
93AphasiaFAERS: 1US FAERS
94Breast FeedingFAERS: 1US FAERS
95BruxismFAERS: 1US FAERS
96Bulimia NervosaFAERS: 1US FAERS
97CardiomegalyFAERS: 1US FAERS
98Cerebral disorderFAERS: 1US FAERS
99ChillsFAERS: 1US FAERS
100Choking sensationFAERS: 1US FAERS
101ChokingFAERS: 1US FAERS
102CholelithiasisFAERS: 1US FAERS
103ChromatopsiaFAERS: 1US FAERS
104Cold sweatFAERS: 1US FAERS
105DeafnessFAERS: 1US FAERS
106Disease recurrenceFAERS: 1US FAERS
107DissociationFAERS: 1US FAERS
108Documented hypersensitivity to administered drugFAERS: 1US FAERS
109DroolingFAERS: 1US FAERS
110Drug DependenceFAERS: 1US FAERS
111Drug abuseFAERS: 1US FAERS
112Drug administration errorFAERS: 1US FAERS
113Drug dispensing errorFAERS: 1US FAERS
114Drug level increasedFAERS: 1US FAERS
115Dry skinFAERS: 1US FAERS
116DyspepsiaFAERS: 1US FAERS
117Economic problemFAERS: 1US FAERS
118Electrocardiogram changeFAERS: 1US FAERS
119Emotional disorderFAERS: 1US FAERS
120Emotional distressFAERS: 1US FAERS
121Erectile dysfunctionFAERS: 1US FAERS
122FlushingFAERS: 1US FAERS
123Genital rashFAERS: 1US FAERS
124GlaucomaFAERS: 1US FAERS
125HostilityFAERS: 1US FAERS
126HungerFAERS: 1US FAERS
127HypomaniaFAERS: 1US FAERS
128HypophagiaFAERS: 1US FAERS
129Initial insomniaFAERS: 1US FAERS
130Intercepted drug dispensing errorFAERS: 1US FAERS
131LabyrinthitisFAERS: 1US FAERS
132Left Ventricular HypertrophyFAERS: 1US FAERS
133LethargyFAERS: 1US FAERS
134Live BirthFAERS: 1US FAERS
135Meconium Aspiration SyndromeFAERS: 1US FAERS
136Memory impairmentFAERS: 1US FAERS
137Metastatic NeoplasmFAERS: 1US FAERS
138Middle insomniaFAERS: 1US FAERS
139Motion SicknessFAERS: 1US FAERS
140MurderFAERS: 1US FAERS
141Muscle RigidityFAERS: 1US FAERS
142Musculoskeletal discomfortFAERS: 1US FAERS
143Neck PainFAERS: 1US FAERS
144Neonatal aspirationFAERS: 1US FAERS
145NephrolithiasisFAERS: 1US FAERS
146Nipple painFAERS: 1US FAERS
147No adverse effectFAERS: 1US FAERS
148Nonspecific reactionFAERS: 1US FAERS
149ParanoiaFAERS: 1US FAERS
150Personality ChangeFAERS: 1US FAERS
151Product availability issueFAERS: 1US FAERS
152Product contaminationFAERS: 1US FAERS
153Product storage errorFAERS: 1US FAERS
154Product use issueFAERS: 1US FAERS
155ProteinuriaFAERS: 1US FAERS
156Renal painFAERS: 1US FAERS
157Sexual DysfunctionFAERS: 1US FAERS
158SinusitisFAERS: 1US FAERS
159SoliloquyFAERS: 1US FAERS
160StubbornnessFAERS: 1US FAERS
161Suppressed lactationFAERS: 1US FAERS
162TachyphreniaFAERS: 1US FAERS
163Teeth brittleFAERS: 1US FAERS
164Therapeutic product ineffectiveFAERS: 1US FAERS
165Tongue bitingFAERS: 1US FAERS
166Tongue discomfortFAERS: 1US FAERS
167nervous system disorderFAERS: 1US FAERS
168skin abrasionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.